Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Discontinued OperationsCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Mimedx Group (MDXG) Other Working Capital Changes: 2011-2024

Historic Other Working Capital Changes for Mimedx Group (MDXG) over the last 14 years, with Dec 2024 value amounting to $1.1 million.

  • Mimedx Group's Other Working Capital Changes rose 406.32% to $3.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $9.5 million, marking a year-over-year increase of 8643.12%. This contributed to the annual value of $1.1 million for FY2024, which is 172.44% up from last year.
  • As of FY2024, Mimedx Group's Other Working Capital Changes stood at $1.1 million, which was up 172.44% from -$1.5 million recorded in FY2023.
  • Mimedx Group's 5-year Other Working Capital Changes high stood at $1.4 million for FY2022, and its period low was -$10.0 million during FY2021.
  • For the 3-year period, Mimedx Group's Other Working Capital Changes averaged around $316,000, with its median value being $1.1 million (2024).
  • Its Other Working Capital Changes has fluctuated over the past 5 years, first tumbled by 838.16% in 2021, then surged by 172.44% in 2024.
  • Over the past 5 years, Mimedx Group's Other Working Capital Changes (Yearly) stood at -$1.1 million in 2020, then tumbled by 838.16% to -$10.0 million in 2021, then spiked by 113.73% to $1.4 million in 2022, then slumped by 211.96% to -$1.5 million in 2023, then skyrocketed by 172.44% to $1.1 million in 2024.